Henk W. Nab
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
The Burden of Systemic Lupus Erythematosus in Germany: Incidence, Prevalence, and Healthcare Resource Utilization.
Journal: Rheumatology and therapy
Published: November 13, 2020
Study protocol for the international Systemic Lupus Erythematosus Prospective Observational Cohort Study (SPOCS): understanding lupus and the role of type I interferon gene signature.
Journal: BMJ open
Published: September 03, 2020
Healthcare Utilization and Costs of Systemic Lupus Erythematosus by Disease Severity in the United States.
Journal: The Journal of rheumatology
Published: June 11, 2020
Lupus Low Disease Activity State and Reduced Direct Health Care Costs in Patients With Systemic Lupus Erythematosus.
Journal: Arthritis care & research
Published: October 15, 2018
Identifying patients with rheumatoid arthritis with moderate disease activity at risk of significant radiographic progression despite methotrexate treatment.
Journal: RMD open
Published: November 11, 2014
Short-term efficacy of etanercept plus methotrexate vs combinations of disease-modifying anti-rheumatic drugs with methotrexate in established rheumatoid arthritis.
Journal: Rheumatology (Oxford, England)
Published: June 08, 2014
Early treatment of psoriatic arthritis is associated with improved patient-reported outcomes: findings from the etanercept PRESTA trial.
Journal: Clinical and experimental rheumatology
Published: October 02, 2013
Association between disease activity and risk of serious infections in subjects with rheumatoid arthritis treated with etanercept or disease-modifying anti-rheumatic drugs.
Journal: Clinical and experimental rheumatology
Published: September 02, 2013
Improved health outcomes with etanercept versus usual DMARD therapy in an Asian population with established rheumatoid arthritis.
Journal: BMC musculoskeletal disorders
Published: May 03, 2012
Randomized comparison of etanercept with usual therapy in an Asian population with active rheumatoid arthritis: the APPEAL trial.
Journal: International journal of rheumatic diseases
Published: April 03, 2012
Last Updated: 09/26/2026